Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC45705 | Thalidomide-NH-PEG1-NH2 hydrochloride Featured |
Thalidomide-NH-PEG1-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
More description
|
![]() |
DC28654 | NH2-PEG6-Boc Featured |
NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More description
|
![]() |
DC22869 | E3 Ligand-Linker Conjugate 3(E3 Ligase Ligand-Linker Conjugates 19) Featured |
An E3 ligase ligand-linker conjugate for PROTAC.
More description
|
![]() |
DC50059 | (S,R,S)-AHPC-C4-NH2 Featured |
(S,R,S)-AHPC-C4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and a linker used for EED-Targeted PROTAC[1].
More description
|
![]() |
DC50057 | E3 ligase Ligand-Linker Conjugates 30 Featured |
E3 ligase Ligand-Linker Conjugates 30 incorporates a cereblon (CRBN) ligand for the E3 ubiquitin ligase, and a PROTAC linker. E3 ligase Ligand-Linker Conjugates 30 can be used to design PROTAC MDM2 degrader[1].
More description
|
![]() |
DC50058 | VH032-C3-NH2((S,R,S)-AHPC-C3-NH2) Featured |
(S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used in PROTAC technology. (S,R,S)-AHPC-C3-NH2 can be used in the synthesis of a series of PROTACs, such as UNC6852. UNC6852 is an EED-targeted bivalent chemical degrader[1].
More description
|
![]() |
DC50060 | (S,R,S)-AHPC-C2-NH2 dihydrochloride Featured |
(S,R,S)-AHPC-C2-NH2 dihydrochloride incorporates a VHL ligand for the E3 ubiquitin ligase, and a PROTAC linker. (S,R,S)-AHPC-OH can be used in the synthesis of a series of PROTACs[1].
More description
|
![]() |
DC50062 | Thalidomide-NH-PEG1-C2-NH2 Featured |
Thalidomide-NH-PEG1-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
More description
|
![]() |
DC50063 | (S,R,S)-AHPC-C6-NH2 Featured |
PROTAC building block.
More description
|
![]() |
DC50065 | (S,R,S)-AHPC-CO-CI-Br Featured |
(S,R,S)-AHPC-CO-CI-Br is a novel protac building block,
More description
|
![]() |
DC50068 | (S,R,S)-AHPC-Me-C10-NH2 Featured |
(S,R,S)-AHPC-Me-C10-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the a VHL ligand and a linker. (S,R,S)-AHPC-Me-C10-NH2 can be used in PROTAC MS432
More description
|
![]() |
DC50069 | (S,R,S)-AHPC-PEG4-NH2(E3 ligase Ligand-Linker Conjugates 7) Featured |
(S,R,S)-AHPC-PEG4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 4-unit PEG linker used in PROTAC technology.
More description
|
![]() |
DC50070 | (S,R,S)-AHPC-PEG2-NH2 (E3 ligase Ligand-Linker Conjugates 6 Free Base) Featured |
(S,R,S)-AHPC-PEG2-NH2 (VH032-PEG2-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker used in the synthesis of PROTACs.
More description
|
![]() |
DC50074 | (S,R,S)-AHPC-Me-C1-NH2 Featured |
(S,R,S)-AHPC-Me-C1-NH2 is a novel PROTAC Building block.
More description
|
![]() |
DC50075 | (S,R,S)-AHPC-Me-C2-NH2 Featured |
(S,R,S)-AHPC-Me-C2-NH2 is a novel PROTAC building block.
More description
|
![]() |
DC50076 | (S,R,S)-AHPC-Me-C3-NH2 Featured |
(S,R,S)-AHPC-Me-C3-NH2 is a novel PROTAC building block.
More description
|
![]() |
DC50077 | (S,R,S)-AHPC-Me-C4-NH2 Featured |
(S,R,S)-AHPC-Me-C4-NH2 is a novel PROTACA building block.
More description
|
![]() |
DC50078 | (S,R,S)-AHPC-Me-C8-NH2 Featured |
(S,R,S)-AHPC-Me-C8-NH2 is a novel PROTAC building block.
More description
|
![]() |
DC50079 | Thalidomide-O-amido-C5-NH2 Featured |
Thalidomide-O-amido-C5-NH2 is a novel PROTAC building block.
More description
|
![]() |
DC47886 | Thalidomide-Piperazine 5-fluoride Featured |
Thalidomide-Piperazine 5-fluoride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
More description
|
![]() |
DC45710 | Pomalidomide-amino-PEG5-NH2 hydrochloride Featured |
Pomalidomide-amino-PEG5-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology.
More description
|
![]() |
DC45712 | Pomalidomide-amino-PEG3-NH2 hydrochloride Featured |
Pomalidomide-amino-PEG3-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology.
More description
|
![]() |
DC12141 | E3 Ligase Ligand-Linker Conjugates 22 Featured |
E3 Ligase Ligand-Linker Conjugates 22 incorporates an E3 ligase ligand and a linker, can be used for the treatment of EZH2-mediated cancer.
More description
|
![]() |
DC46473 | Lenalidomide-C9-aldehyde |
Lenalidomide-C9-aldehyde is a synthesized E3 ligase ligand-linker conjugate that incorporates the Lenalidomide based cereblon ligand and a linker. Lenalidomide-C9-aldehyde can be used in the synthesis of a series of PROTACs, such as INY-03-041. INY-03-041 is a potent, highly selective and PROTAC-based pan-Akt degrader. INY-03-041 inhibits Akt1, Akt2 and Akt3 with IC50s of 2.0 nM, 6.8 nM and 3.5 nM, respectively.
More description
|
![]() |
DC29019 | N3-PEG3-CH2CH2COOH |
N3-PEG3-CH2CH2COOH a PEG-based PROTAC linker can be used in the synthesis of BI-3663, BI-4216 and BI-0319. Azido-PEG3-acid is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More description
|
![]() |
DC42556 | Thalidomide-NH-PEG4-COOH |
Thalidomide-NH-PEG4-COOH is an E3 ligase ligand-linker conjugate which can be used for synthesizing dCBP-1. dCBP-1 is a potent and selective heterobifunctional degrader of p300/CBP.
More description
|
![]() |
DC46258 | VHL Ligand-Linker Conjugates 17 |
VHL Ligand-Linker Conjugates 17 incorporates a VHL ligand for the E3 ubiquitin ligase, and a PROTAC linker. VHL Ligand-Linker Conjugates 17 can be used in the synthesis of a series of PROTACs, such as ARD-266. ARD-266 is a highly potent androgen receptor (AR) PROTAC degrader.
More description
|
![]() |
DC46474 | Lenalidomide-PEG3-iodine |
Lenalidomide-PEG3-iodine is a synthesized E3 ligase ligand-linker conjugate that incorporates the Lenalidomide based cereblon ligand and a 3-unit PEG linker. Lenalidomide-PEG3-iodine can be used in the synthesis of a series of PROTACs, such as SJF620. SJF620 is a potent PROTAC BTK degrader with a DC50 of 7.9 nM.
More description
|
![]() |
DC46472 | (S,R,S)-AHPC-C3-NH2 TFA |
(S,R,S)-AHPC-C3-NH2 TFA (VH032-C3-NH2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used in PROTAC technology. (S,R,S)-AHPC-C3-NH2 can be used in the synthesis of a series of PROTACs, such as UNC6852. UNC6852 is an EED-targeted bivalent chemical degrader.
More description
|
![]() |
DC40422 | Pomalidomide-amido-C1-Br |
Pomalidomide-amido-C1-Br is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker. Pomalidomide-amido-C1-Br can be used to design a B-Raf PROTAC degrader PROTAC B-Raf degrader 1. PROTAC B-Raf degrader 1 has anti-cancer activity.
More description
|
![]() |